CoverageForm 410-K10-Q8-K13D13G13F

BUKS Butler National Corp - 8-K

Accession
0000015847-26-000009
8.019.01

Item 8.01 - Other Events

192 words

Item 8.01

Other Events

On June 1, 2026, Christopher J. Reedy, Chief Executive Officer of Butler National Corporation (“Butler National”), sent an email to Butler National employees regarding a course of medical treatment he is currently undergoing following recent consultations with his physicians at the Mayo Clinic. A copy of the email is attached as Exhibit 99.1.

Mr. Reedy will continue serving as Chief Executive Officer and will remain actively engaged with Butler National’s operations, leadership team, and Board of Directors. While certain aspects of his treatment may periodically require time away from the office, Butler National’s executive leadership team and Board will continue working closely together to support ongoing operations, strategic initiatives, and long-term objectives.

Executive Chairman Jeffrey D. Yowell stated, “Chris is a valued leader and friend, and the Board fully supports him during this treatment process. Butler National has a strong leadership team in place, and we will continue working collaboratively to advance our operational and strategic priorities.”

Lead Independent Director Joseph P. Daly added, “We remain confident in Chris’ leadership and are appreciative of the support and commitment demonstrated across the Butler National management team during this period.”

Item 9.01 - Financial Statements and Exhibits

32 words

Item 9.01

Financial Statements and Exhibits

Exhibit 99.1

Email of Christopher J. Reedy, Chief Executive Officer of Butler National

Exhibit 104

Cover Page Interactive Data File (embedded within the Inline XBRL document)